ArticleJournal of neuro-oncology2026
Modulation of VEGF and IL-2 in radiation-induced brain injury: neuroprotective effects of melatonin and ascorbic acid in rats.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study investigates the neuroprotective effects of melatonin and ascorbic acid, alone and in combination, on radiation-induced brain injury, specifically focusing on vascular and immunological modulations.
methodsThirty-three male Wistar-Albino rats were assigned to five groups: Control (G1), Radiotherapy (RT) only (single dose 20 Gy) (G2), RT + Melatonin (20 mg/kg) (G3), RT + vitamin C (100 mg/kg) (G4), and RT + Melatonin + Vitamin C (G5). The treatments were administered intraperitoneally the day after RT. Brain tissues were evaluated 28 days post-irradiation for histopathological neural damage, vasocongestion, and immunohistochemical expression of vascular endothelial growth factor (VEGF) and interleukin-2 (IL-2).
resultsHigh-dose RT significantly increased vasocongestion and neuronal damage while suppressing VEGF expression and elevating IL-2 levels (p < 0.001). Both melatonin and ascorbic acid effectively reduced histopathological injury, maintained VEGF levels, and balanced IL-2 expression compared to the RT-only group (p < 0.05). However, combining both agents provided no significant synergistic advantage over monotherapies. Notably, single-fraction high-dose RT resulted in a marked suppression of VEGF expression, suggesting an impaired vascular synthetic capacity rather than a compensatory angiogenic response.
conclusionMelatonin and ascorbic acid provide substantial neuroprotection against radiation-induced brain injury by preserving vascular integrity and modulating local immune responses. These antioxidants represent potential therapeutic strategies for minimizing RT-induced neurotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.